In diabetic animals (Table 1), pharmacological agonism of PPARα or PPARγ alleviated the DCM phenotype, likely by normalizing myocardial insulin-stimulated glucose uptake and reducing myocardial FA misuse and accumulation [19,27,31-33,38]. This evidence concerns the gene PPARA and familial dilated cardiomyopathy.